China has released new expert consensus on HbA1c POCT, emphasizing its role in diabetes screening at primary care. Learn how your clinic in Malaysia or Thailand can benefit using rapid 15-min fluorescent immunoassay systems.

This kit is applicable to the in vitro quantitative detection on the content of glycated hemoglobin (HbA1c) in human whole blood samples and is mainly used for implementing auxiliary diagnosis of diabetes and monitor blood glucose level.

The HBA1C test kit is a product used to rapidly detect the level of HBA1c in the blood. Hemoglobin A1C is the combination of hemoglobin and glucose in red blood cells, which can reflect the average blood sugar level of a person in the past 2-3 months, and is an important indicator to evaluate the blood sugar control of diabetes patients.

In 2021, there were 521 million people suffering from diabetes worldwide, the number of it remains on rise and is forecast to reach to 1.31 billion by 2050. As a leading cause of blindness, kidney failure, heart attack, stroke, and lower limb amputation, prevention for and control of diabetes is an urgent matter.

Normally people have three kinds of hemoglobin: HbA, HbF, HbA2, while adult red blood cells mainly contain HbA. HbA1c is glycosylated hemoglobin, formed by HbA in the metabolic process and glucose, so it can accurately reflect the glucose level in the blood.